Docosatetraenylethanolamide, CAS 150314-35-5

Product Description: Docosatetraenylethanolamide (DEA) is a cannabinoid receptor 1 (CB1) agonist. Docosatetraenylethanolamide inhibits the specific binding of cannabinoid probe to rat synaptosomal membranes with a Ki value of 34.4 nM. Docosatetraenylethanolamide can be used in the research of nervous system[1][2].

Applications: Metabolism-protein/nucleotide metabolism

Formula: C24H41NO2

References: [1]Hanus L, et al. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J Med Chem. 1993 Oct 1;36(20):3032-4./[2]Pertwee R, et alcts of two endogenous fatty acid ethanolamides on mouse vasa deferentia. Eur J Pharmacol. 1994 Jul 1;259(2):115-20./[3]Walter L, et al. Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem. 2002 Jun 7;277(23):20869-76.

CAS Number: 150314-35-5

Molecular Weight: 375.59

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Cannabinoid Receptor;Endogenous Metabolite

• Artikelnummer: MEXHY-110016-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-110016-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK